Journal: bioRxiv
Article Title: Abnormal hyperactivity of specific striatal ensembles encodes distinct dyskinetic behaviors revealed by high-resolution clustering
doi: 10.1101/2024.09.06.611664
Figure Lengend Snippet: (A) Cartoon of a mouse head showing the micro-endoscope on top of the mouse head connected to a 1 mm GRIN lens placed in the dorso-lateral striatum and the wireless IMU on the back of the micro-endoscope. On the right, coronal sections of two example mouse brains at the level of the striatum. Photomicrographs were acquired from A2a-Cre transgenic intact (A2a Int, top row) and 6-OHDA lesioned (A2a Les, bottom row) mice injected intrastriatally with the AAV5-GCamP6f viral vector. GFP expression (revealed with GFP antibody in green) in the dorso-lateral striatum shows the region of the striatum transduced with AAV5-GCamP6f viral vector, which is expressed below the 1 mm lens. TH (tyrosine hydroxylase, in red) shows the dopamine terminals in the striatum (note that A2a Les has a complete dopamine depletion shown by the lack of TH immunostaining in the right striatum). Merged photograph shows colocalization of GFP and TH showing the expression of GCamP6f in an intact (top) and a lesioned striatum (bottom) (scale bar: 1 mm). (B) Field of view of the striatum (striatal F.O.V.) through the lens of a D1-Cre lesioned mouse treated with LD, corresponding to a maximum projection of 3000 frames of the video recording. Fluorescent calcium signal shows increased fluorescence in neuronal somas (example neurons depicted by the arrows) and lack of fluorescence of a blood vessel (shown by an asterisk). Right picture shows the same F.O.V. with the total number of neurons (283 neurons) detected with the CNMFe algorithm during both BL and LD sessions, shown as footprints or ROIs (regions of interest) colored in green (scales: 60 µm). (C) Event rate of D1-SPNs in Int and Les mice treated with VEH and LD. On the left, example traces of n = 3 neurons of Int (gray, top row) and n = 3 neurons of Les (red, bottom row) mice (scale bar: 200 sec). First column corresponds to traces at BL and after VEH and the second column shows traces at BL and after LD (note that BL and VEH/LD are separated by a dashed line). Bar graph represents the average of the event rates (events/s) per mouse and session when moving (move) ± SEM (n = 3-7 mice per group and 6 to 18 sessions per group). Ordinary 1-way ANOVA, F (3, 18) = 15.60, p < 0.001. Post hoc Bonferroni’s multiple comparisons test shows ***p < 0.001 Les-LD vs. Les-VEH; # p < 0.05 Les-LD vs. Int-LD; ## p < 0.005 Les-VEH vs. Int-VEH. The bar graph on the right shows the event rates when the mice are at rest. Note that the Les-LD group is not represented because Les-LD mice did not rest (see STAR Methods). Ordinary 1-way ANOVA, F (2, 12) = 1.889, p = 0.1936 (see Movie S3 for D1-SPN calcium imaging aligned to the video camera recording). (D) Event rate of D2-SPNs in Int and Les mice treated with VEH and LD. On the left, example traces of n = 3 neurons of Int and Les mice as in (C). Bar graph represents the average of event rates (events/s) per mouse and session ± SEM (n = 6 mice per group and 8 to 14 sessions per group). Ordinary 1-way ANOVA, F (3, 20) = 10.59, p = 0.0002. Post hoc Bonferroni’s multiple comparisons test shows ***p < 0.001 Les-LD vs. Les-VEH; # p < 0.05 Les-LD vs. Int LD. Bar plot on the right shows the event rates when mice are at rest. Ordinary 1-way ANOVA, F (2, 15) = 29.11, p < 0.001. Post hoc Bonferroni’s multiple comparisons test shows ### p < 0.001 Les-VEH vs. Int-VEH (see Movie S4 for D2-SPN calcium imaging aligned to the video camera recording). (E) Number of active (detected with CNMFe algorithm) D1-SPNs in Int and Les mice treated with VEH and LD when mice were moving. The plots show the number of active neurons ± SEM (n = 3-7 mice per group and 6 to 18 sessions per group). Ordinary 1-way ANOVA, F (3, 19) = 3.561, p = 0.0338. Post hoc Bonferroni’s multiple comparisons test shows *p < 0.05 Les-LD vs. Les-VEH. (F) Number of active D2-SPNs in Int and Les mice treated with VEH and LD. The plots show the number of active neurons ± SEM (n = 6 mice per group and 8 to 14 sessions per group). Ordinary 1-way ANOVA, F (3, 20) = 3.134, p = 0.0484. Post hoc Bonferroni’s multiple comparisons test shows *p < 0.05 Les-LD vs. Les-VEH. (G) Spatiotemporal cross-correlation between pairs of active SPNs of Les mice after VEH vs. LD. For D1-SPNs, two-way repeated measures ANOVA shows an effect of the distance , F (8,54) = 195.9, p < 0.001; no effect of the treatment , F (1,54) = 0.0088, p = 0.9257; and an effect of the interaction, F (8, 54) = 2.421, p = 0.0259. Post hoc Bonferroni’s multiple comparisons test shows **p < 0.01 at 31 µm distance between VEH and LD (squared inset from 30 to 73µm). For D2-SPNs, two-way repeated measures ANOVA shows an effect of the distance , F (8,45) = 108.5, p < 0.001; the treatment , F (1,45) = 8.651, p = 0.0051; and the interaction, F (8, 45) = 2.750, p = 0.0146. Post hoc Bonferroni’s multiple comparisons test shows ***p < 0.001 at 31 µm distance between VEH and LD (squared inset from 30 to 73µm). (H) Comparison of the spatiotemporal cross-correlation between pairs of active D1-SPNs vs. D2-SPNs of Les mice after LD. Two-way repeated measures ANOVA shows an effect of the distance , F (8,88) = 193.8, p < 0.001; a smaller effect of the treatment , F (1,11) = 4.984, p = 0.0473; and an effect of the interaction, F (8,88) = 4.741, p < 0.001. Post hoc Bonferroni’s multiple comparisons test shows ***p < 0.001 at 31 µm distance between D1-SPN and D2-SPN. (I) Comparison of the spatiotemporal cross-correlation between pairs of active D1-SPNs vs. D2-SPNs of Les mice after VEH. Two-way repeated measures ANOVA shows an effect of the distance , F (8,88) = 246.5, p < 0.0001; no effect of the treatment , F (1,11) = 0.4845, p = 0.5008; and an effect of the interaction, F (8,88) = 2.92, p < 0.01. Post hoc Bonferroni’s multiple comparisons test shows no significant difference at any distance between D1-SPN and D2-SPN.
Article Snippet: The study was performed in bacterial artificial chromosome (BAC) transgenic mice expressing Cre recombinase under the control of the dopamine D1 receptor (D1-Cre, Tg(Drd1a-cre) FK150Gsat/Mmucd; MMRRC #029178-UCD) for targeting of direct-pathway SPNs, and adenosine A2a receptor (A2a-Cre, B6.FVB(Cg)-Tg(Adora2acre) KG139Gsat/Mmucd; MMRRC #036158-UCD) for targeting indirect-pathway SPNs.
Techniques: Transgenic Assay, Injection, Plasmid Preparation, Expressing, Transduction, Immunostaining, Fluorescence, Imaging, Comparison